Biomarker Analysis Data From a Randomized Phase II Study in Patients With Nasopharyngeal Carcinoma Treated With Chemotherapy and Radiotherapy

NCT07741110 · clinicaltrials.gov ↗

COMPLETED

Status

141

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma (NPC)

Interventions

GENETIC: Next generation sequencing
GENETIC: Immunohistochemistry/CISH

Sponsor

Hellenic Cooperative Oncology Group